Prospective Biospecimen Collection Services

Prospective Biospecimen
Collection Services

Sanguine prospective biospecimen collection
including blood, stool, urine, and leukopaks

Sanguine's prospective biospecimen collections offer a flexible, on-demand solution tailored to your research needs. Through our direct-to-donor model, we provide fresh, high-quality samples collected at the precise time points you require. Whether you need specific disease-state samples, healthy controls, or longitudinal collections, our expansive donor network covering over 100 diagnosed conditions ensures access to the exact biospecimens you need. With customizable collection protocols and seamless logistics, Sanguine accelerates your research while maintaining the highest standards of quality and compliance. Discover how our prospective collections can elevate your next study.

You define the criteria for your samples, and Sanguine handles everything else.

Ensuring your project can come to fruition is essential and we pride ourselves in if we stay we can do it, we can. How are we so confident in our ability to assess feasibility? First, we tap into our extensive donor network. Sometimes, though, we need to expand our search. One of our avenues is engaging with patient advocacy groups and foundations to connect with potential donors.

Human biospecimens we collect

Our experienced phlebotomy team collects samples in the donor's home or at an apheresis center. We can collect multiple types of samples at a single visit, perform collections for longitudinal studies, and further process samples in-home or send to our lab depending upon your needs.

Blood derived biofluids and products

Whole blood
Serum
Plasma
Buffy coat
Peripheral blood mononuclear cells

Non-Blood Derived Biofluids

Nasal mucosa swabs
Non-induced sputum
Saliva
Semen
Stool
Urine

Integumentary
Tissues

Fingernails
Hair
Skin

Apheresis
Products

LeukoCore™ RUO leukopaks
LeukoLot™ PBMC
LeukoCert™ GMP-grade leukopaks

How do we find the biospecimens you need?

The short answer - our Donor Network of 70,000 and growing. We have over 100 verified-diagnosed conditions including rare diseases. With our comprehensive donor data, partnerships with over 100 non-profit and patient advocacy groups, we can find the donors to fit your I/E criteria.

Donor Access and Engagement
Strategies for reach, recruitment, retention
Geographic and demographic diversity
Diversity of disease states
Donor Centric
Study Design Capabilities
Sample collection
Participant retention
(longitudinal studies)
Donor Data
Post-collection processing
Clinically Relevant Annotated Specimens
Sample integrity
Samples and data collected by Sanguine
Longitudinal sampling
Simultaneous collection of multiple specimen types
Large volume collection (≤180 mL)
Patient-reported outcomes data
(PRO, ePRO)
Same-day sample collection and delivery
Specialty Biospecimen Collection
Leukopaks (leukocyte-enriched apheresis products)
Healthy specimens collected at client’s facilities

Direct Donor Access
Sanguine Model

Donor Access and Engagement
Strategies for reach, recruitment, retention Mobile, virtual, flexible
Geographic and demographic diversity Nationwide, urban or rural
Diversity of disease states Broad with over 100 diagnosed conditions
Donor Centric Engaged homegrown communities
Study Design Capabilities
Sample collection Prospective
Participant retention
(longitudinal studies) High retention rates >95%
Donor Data FHIR electronic health records, demographics, ability to add surveys, questionnaires, and outcomes
Post-collection processing Customize parameters and procedures
Clinically Relevant Annotated Specimens
Sample integrity
Samples and data collected by Sanguine
Longitudinal sampling
Simultaneous collection of multiple specimen types
Large volume collection (≤180 mL)
Patient-reported outcomes data
(PRO, ePRO)
Same-day sample collection and delivery
Specialty Biospecimen Collection
Leukopaks (leukocyte-enriched apheresis products)
Healthy specimens collected at client’s facilities